Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
0.3070
Nov 13 • 3:59 PM ET Dollar change+0.0170 Percentage change(5.86%)
Aftermarket Close
0.2900
Aftermarket • 5:16 PM ET Dollar change-0.0170 Percentage change(-5.54%)
Nov 13, 5:18 PMMilestone targets Q4 2026 profitability, reaffirms 2026 guidance as medical revenue jumps 136%
Index
-
Market Cap
27.83M
Enterprise Value
26.62M
Income
-3.74M
Sales
9.28M
Book/sh
0.04
Cash/sh
0.01
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
15
IPO
Nov 03, 1995
P/E
-
Forward P/E
-
PEG
-
P/S
3.00
P/B
7.61
P/C
21.08
P/FCF
-
EV/EBITDA
-
EV/Sales
2.87
Quick Ratio
1.23
Current Ratio
2.06
Debt/Eq
0.03
LT Debt/Eq
0.00
Option/Short
Yes / Yes
EPS (ttm)
-0.04
EPS next Y
-0.04
EPS next Q
-0.01
EPS this Y
42.86%
EPS next Y
12.50%
EPS next 5Y
34.14%
EPS past 3/5Y
17.32% 9.75%
Sales past 3/5Y
0.63% 10.54%
EPS Y/Y TTM
43.78%
Sales Y/Y TTM
3.93%
EPS Q/Q
42.86%
Sales Q/Q
-5.95%
Insider Own
16.08%
Insider Trans
0.00%
Inst Own
5.22%
Inst Trans
0.46%
ROA
-48.45%
ROE
-120.45%
ROIC
-102.02%
Gross Margin
70.07%
Oper. Margin
-40.04%
Profit Margin
-40.27%
SMA20
-0.86%
SMA50
-14.61%
SMA200
-13.52%
Trades
Shs Outstand
90.61M
Shs Float
76.07M
52W High
0.58 -47.03%
52W Low
0.22 40.76%
Volatility
8.93% 10.28%
ATR (14)
0.03
RSI (14)
44.67
Beta
1.17
Rel Volume
1.28
Avg Volume
114.05K
Volume
146,281
Perf Week
1.66%
Perf Month
-6.03%
Perf Quarter
-37.09%
Perf Half Y
-6.03%
Perf YTD
12.45%
Perf Year
-19.15%
Perf 3Y
-63.84%
Perf 5Y
-87.37%
Perf 10Y
-82.94%
Prev Close
0.29
Price
0.31
Change %
5.86%
Consensus
Strong Buy
Avg. Price Target
$1.25
Implied Upside
+307.2%
Analysts2incl. previous ratings
Rating Distribution1 Buy · 1 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Sep 16, 2020Initiated
NNorthland Capital
Market Perform
Nov 16, 2018Reiterated
MMaxim Group
Buy$3 → $1.50+388.6%
Dec 23, 2016Reiterated
MMaxim Group
Buy$5 → $4+1,202.9%
Dec 11, 2015Initiated
MMaxim Group
Buy$5+1,528.7%
Milestone Scientific, Inc. is a biomedical technology research and development company, which patents, designs, and develops diagnostic and therapeutic injection technologies and instruments. It operates through the following segments: Dental, Medical, and Corporate. The Corporate segment refers to executive management, investor relations, patents, trademarks, licensing agreements, new instruments developments, financing activities, and public company compliance costs. Its solutions include CompuFlo Epidural, CathCheck Verification System, and Single Tooth Anesthesia System. The company was founded on August 17, 1989 and is headquartered in Roseland, NJ.
Executive ChairmanMs. Benedetta I. Casamento
CEOMr. Eric C. Hines
FounderMr. Leonard A. Osser
M.S.Ms. Keisha Harcum M.B.A.
Senior VP and Global Head of Sales & MarketingMr. Jason Papes